Release 5.9.0: Saved Query Alerts, Query Details, Collection Sizes and more!

Saved Query Alerts.

Receive a notification email when new data is added for your saved queries.

Query Details Improvements.

View details of your joined query when navigating between cited/citing panes.

Collection Limit Increase.

Create collections of up to 50,000 Patents or Scholarly Works.

Pharmaceutical Composition For The Treatment Of Kidney Or Liver Fibrosis


The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.


The present invention relates to the use of an antibody that specifically binds to integrin alpha ny beta 6 and blocks binding of a ligand to integrin alpha ny beta 6 for the preparation of a medicament intended for treating kidney or liver fibrosis in a patient wherein the antibody is a monoclonal antibody and wherein the antibody is intended for therapeutic or prophylactic administration. There are also disclosed monoclonal antibodies produced by a hybridoma ATCC HB12382 and the hybridoma ATCC HB12382 per se.


Information currently unavailable.

IPC Classifications
Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Nov 19, 2008
  • Application: Aug 7, 1998
    CZ CZ 20000413 A
  • Priority: Aug 8, 1997
    US US 5506097 P

Sign in to the Lens